By Dennis Thompson HealthDay ReporterMONDAY, July 7, 2025 (HealthDay News) — Radiation therapy to treat cancer might be a ...

Corticosteroids, a commonly prescribed medication to alleviate cancer-related symptoms for non-small cell lung cancer ...

The treatment marks the only targeted oral treatment in patients with non–small cell lung cancer with epidermal growth factor ...

The FDA granted accelerated approval to the tyrosine kinase inhibitor sunvozertinib (Zegfrovy) for advanced non-small cell ...

A 79-year-old man with recurrent oropharyngeal cancer has developed the first documented case of severe drug-induced interstitial lung disease following photoimmunotherapy with cetuximab-sarotalocan ...

This newly launched program can save lives, with the proportion of cases identified at an early stage expected to rise from ...

Corticosteroids, a commonly prescribed medication to alleviate cancer-related symptoms for non-small cell lung cancer ...

The new lung cancer screening program needs to be independently evaluated to keep it on track, and to minimise the harms.

Screening for disease, including cancer, can cause harm —during screening, diagnosis and treatment. With lung cancer ...

More cancer is being spotted sooner in a screening programme which has “flipped” statistics for patients’, NHS bosses were told.

Nearly a quarter of all newly-diagnosed patients with advanced lung cancer are not given a test that could improve their chances for long-term survival and reduce their side effects.

Cancer is not a welcome diagnosis, but breakthroughs in genetic sequencing and immunotherapy are making some cancers easier ...